|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2025―Mar―28 |
Corrigendum to: Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster |
Jun Liu, Jing Sun, Liping Luo, Yanhong Tang, Hu Guo, Yiyun He, Qi Liu, Xuya Yu, Yumei Huang, Siyuan Zhang, Airu Zhu, Jun Dai, Fan Zhang, Tao Huang, Jincun Zhao, Yucai Peng |
2 |
[GO] |
2024―Nov―27 |
In Silico Analysis of Cross-Species Sequence Variability in Host Interferon Antiviral Pathway Proteins and SARS-CoV-2 Susceptibility |
Sally A. Mayasich, Peter G. Schumann, Maxwell Botz, Carlie A. LaLone |
3 |
[GO] |
2024―May―18 |
Long-Term Protection from SARS-CoV-2 Variants in Mice by a Phase II Clinically Evaluated Original mRNA Vaccine Booster |
Jun Liu, Jing Sun, Liping Luo, Yanhong Tang, Hu Guo, Yiyun He, Qi Liu, Xuya Yu, Yumei Huang, Siyuan Zhang, Airu Zhu, Jun Dai, Fan Zhang, Tao Huang, Jincun Zhao, Yucai Peng |
4 |
[GO] |
2024―Feb―14 |
Factors Associated with the Clinical Severity and Disease Burden of COVID-19 Caused by Omicron BA.2 in Shanghai and Hong Kong, China |
Ruijia Sun, Xinhua Chen, Yanpeng Wu, Hongjie Yu |
5 |
[GO] |
2024―Feb―01 |
The Intra-Host Evolution of SARS-CoV-2 After Neutralizing Antibody Therapy, Revealed by Nanopore Sequencing |
Hong-Xiang Zeng, Wen-Hong Zu, Hai-Yan Wang, Jing Yuan, Lin Cheng, Gang Xu, Yi-Gan Huang, Yang Liu, Shu-Ye Zhang, Zheng Zhang |
6 |
[GO] |
2024―Jan―10 |
Emergence and Characterization of the SARS-CoV-2 JN.1 Variant: Global Prevalence and Implications for Public Health |
Hang Fan, Si Qin, Yujun Cui |
7 |
[GO] |
2023―Dec―31 |
Health Consequences Among COVID-19 Convalescent Patients 30 Months Post-Infection in China |
Yu Yin, Yi Guo, Mingzhong Xiao, Qinlin Chen, Pinpin Long, Xi Wang, Jingzhi Wang, Zuoyu Shao, Yutong Qiu, Yixuan Lu, Yuchan Yang, Xueqin Shi, Wei Ni, Shanshan Cheng, Qi Wang, Li Liu, Tangchun Wu, Xiaodong Li, Hao Wang, Yu Yuan |
8 |
[GO] |
2023―Dec―01 |
Clinical Application of SARS-CoV-2 IgM and IgG Antibody Detection Using the Colloidal Gold Immunochromatography Assay |
Lipeng Liu, Kangping Zhou, Yan Xing, Wei Luo, Bing Pei, Junqiang Xu, Lei Yi, Honglei Wang, Juan Wang, Wei Zhang, Fei Yu, Kun Cai, Peng Liu |
9 |
[GO] |
2023―Nov―17 |
Pandemic COVID-19 and Endemic Neglected Tropical Diseases: Friends or Foes? |
Mehdi Borhani Zarandi, Xuemin Jin, Saeid Fathi, Majid Fasihi Harandi, Sami Simsek, Mohammad Mehdi Ommati, Mingyuan Liu, Jing Ding |
10 |
[GO] |
2023―Apr―21 |
Co-circulation, Co-infection of SARS-CoV-2 and Influenza Virus, Where Will it Go? |
Shuai-xing Wang, Da-yan Wang |
11 |
[GO] |
2023―Apr―19 |
Next-Generation Vaccines against COVID-19 Variants: Beyond the Spike Protein |
Srinivasa Reddy Bonam, Haitao Hu |
12 |
[GO] |
2022―Sep―21 |
Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies |
Jingxin Li, Zhuopei Li, Yawen Zhu, Li Zhou, Fengcai Zhu |
13 |
[GO] |
2022―Sep―06 |
Effectiveness of Inactivated SARS-CoV-2 Vaccines During a Delta Variant Outbreak in Hunan Province, China: A Retrospective Cohort Study |
Xuemei Yan, Zhihui Dai, Qianhui Wu, Xiaolei Wang, Yan Wang, Ge Zeng, Yanpeng Wu, Shengbao Chen, Lan Yi, Hongjie Yu, Lidong Gao |
14 |
[GO] |
2022―Apr―01 |
The Animal Origin of Major Human Infectious Diseases: What Can Past Epidemics Teach Us About Preventing the Next Pandemic? |
Guha Dharmarajan, Ruiyun Li, Emmanuel Chanda, Katharine R. Dean, Rodolfo Dirzo, Kjetill S. Jakobsen, Imroze Khan, Herwig Leirs, Zheng-Li Shi, Nathan D. Wolfe, Ruifu Yang, Nils Chr. Stenseth |
15 |
[GO] |
2022―Feb―08 |
SARS-CoV-2 Variants and Vaccination |
Yang Liu, Jianying Liu, Pei-Yong Shi |
16 |
[GO] |
2022―Jan―25 |
Isothermal Amplification Technology for Diagnosis of COVID-19: Current Status and Future Prospects |
Xuejun Ma |
17 |
[GO] |
2022―Jan―06 |
Online Education in Human Parasitology during the COVID-19 Pandemic in Wuhan: Our Experiences, Challenges, and Perspectives |
Jiahui Lei, Fei Guan, Honggang Zhu, Wenqi Liu |
18 |
[GO] |
2021―Dec―03 |
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) |
Si Qin, Mengnan Cui, Siqi Sun, Jiyang Zhou, Zongmin Du, Yujun Cui, Hang Fan |
19 |
[GO] |
2021―Sep―15 |
Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic |
Xin Li, Kelvin Kai-Wang To, Kwok-Yung Yuen |
20 |
[GO] |
2021―Sep―04 |
Analysis of Intermediate Hosts and Susceptible Animals of SARS-CoV-2 by Computational Methods |
Yueying Yang, Mengzhu Zheng, Yang Liu, Yali Wang, Yang Xu, Yirong Zhou, Dejuan Sun, Lixia Chen, Hua Li |
21 |
[GO] |
2021―Aug―31 |
SARS-CoV-2 Lambda Variant: Spatiotemporal Distribution and Potential Public Health Impact |
Cao Chen, Qi Shi, Xiao-Ping Dong |
22 |
[GO] |
2021―Aug―26 |
Dynamic Changes in Chest CT Images Over 167 Days in 11 Patients with COVID-19: A Case Series and Literature Review |
Jianqin Liang, Guizeng Liu, Shuzhuang Yu, Yang Yang, Yanchun Li, Hongli Tian, Zhe Chen, Wenping Gong |
23 |
[GO] |
2021―Aug―17 |
Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact |
Qi Shi, Xiao-Ping Dong |